Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- FNSR +16.9%, ZUMZ +3.6%, (also reports August comps fell 1.1% vs. -10.7% last year), DLTH +2.9%, EGAN +2.9%, PPHM +2.7%, BRC +0.9%
M&A news:
- LPTN +41.5% (Lpath announces definitive merger agreement with Apollo Endosurgery ), .
Select EU financial related names showing strength:
- DB +3.9%, RBS +2.2%, CS +1.8%, LYG +1.6%, BCS +1.4%, HSBC +1.1%
Other news:
- LXRX +21.6% (reports that the pivotal inTandem1 Phase 3 clinical trial of sotagliflozin met its primary endpoint)
- SWFT +6.7% (Swift Transportation CEO Jerry Moyes to retire, COO Richard Stocking has been unanimously appointed by the Board as CEO)
- LOCO +6.1% (to join the S&P SmallCap 600), OCLR +4.8% (Kopp Family Office discloses 6.9% passive stake; also FNSR sympathy)
- CLCD +3.1% ( commences common stock offering)
- WSM +1.3% (RH sympathy)
Analyst comments:
- EGAN +2.9% (upgraded to Buy at Ladenburg Thalmann)
- MPEL +1.5% (upgraded to Buy at Deutsche Bank)